BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38956568)

  • 1. Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy.
    Brinkhuis F; Julian E; van den Ham H; Gianfrate F; Strammiello V; Berntgen M; Pavlovic M; Mol P; Wasem J; Van Dyck W; Cardone A; Dierks C; Schiel A; Bernardini R; Solà-Morales O; Ruof J; Goettsch W
    Health Res Policy Syst; 2024 Jul; 22(1):74. PubMed ID: 38956568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
    Desmet T; Julian E; Van Dyck W; Huys I; Simoens S; Giuliani R; Toumi M; Dierks C; Dierks J; Cardone A; Houÿez F; Pavlovic M; Berntgen M; Mol P; Schiel A; Goettsch W; Gianfrate F; Capri S; Ryan J; Ducournau P; Solà-Morales O; Ruof J
    J Mark Access Health Policy; 2024 Mar; 12(1):21-34. PubMed ID: 38544972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European access academy.
    Julian E; Pavlovic M; Sola-Morales O; Gianfrate F; Toumi M; Bucher HC; Dierks C; Greiner W; Mol P; Bergmann JF; Salmonson T; Hebborn A; Grande M; Cardone A; Ruof J
    Health Econ Rev; 2022 Nov; 12(1):54. PubMed ID: 36333433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of stakeholder involvement in the evolving EU HTA process:
    Van Haesendonck L; Ruof J; Desmet T; Van Dyck W; Simoens S; Huys I; Giuliani R; Toumi M; Dierks C; Dierks J; Cardone A; Houÿez F; Pavlovic M; Berntgen M; Mol PGM; Schiel A; Goettsch W; Gianfrate F; Capri S; Ryan J; Ducournau P; Solà-Morales O; Julian E
    J Mark Access Health Policy; 2023; 11(1):2217543. PubMed ID: 37284060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.
    Uzochukwu BSC; Okeke C; Shuaib F; Torres-Rueda S; Vassall A; Jit M; Nonvignon J; Uzochukwu AC; Ruiz F
    Health Res Policy Syst; 2024 Jun; 22(1):73. PubMed ID: 38926716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholder perspectives on cooperation in the clinical and nonclinical health technology assessment domains.
    Zimmermann G; Michelmore S; Hiligsmann M
    Int J Technol Assess Health Care; 2023 May; 39(1):e29. PubMed ID: 37212049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.
    Aryankhesal A; Behzadifar M; Bakhtiari A; Shahabi S; Azari S; Darvishi Teli B; Rezapour A; Ehsanzadeh SJ; Behzadifar M
    Health Res Policy Syst; 2024 Jan; 22(1):11. PubMed ID: 38225573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European collaboration on health technology assessment: looking backward and forward.
    Ruether A; Imaz-Iglesia I; Bélorgey C; Lo Scalzo A; Garrett Z; Guardian M
    Int J Technol Assess Health Care; 2022 Apr; 38(1):e34. PubMed ID: 35437132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUnetHTA's contribution to the new legal framework for health technology assessment cooperation in Europe.
    Imaz-Iglesia I; Wild C
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e50. PubMed ID: 35652661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems to support health technology assessment (HTA) in member states of the European union with limited institutionalization of HTA.
    Moharra M; Espallargues M; Kubesch N; Estrada MD; Parada A; Vondeling H; Lo Scalzo A; Cristofides S; Turk E; Raab M;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():75-83. PubMed ID: 20030894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTA Implementation Roadmap in Central and Eastern European Countries.
    Kaló Z; Gheorghe A; Huic M; Csanádi M; Kristensen FB
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):179-92. PubMed ID: 26763688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
    Woodford Guegan E; Cook A
    Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposal for a regulation on health technology assessment in Europe - opinions of policy makers, payers and academics from the field of HTA.
    Vella Bonanno P; Bucsics A; Simoens S; Martin AP; Oortwijn W; Gulbinovič J; Rothe C; Timoney A; Ferrario A; Gad M; Salem A; Hoxha I; Sauermann R; Kamusheva M; Dimitrova M; Petrova G; Laius O; Selke G; Kourafalos V; Yfantopoulos J; Magnusson E; Joppi R; Jakupi A; Bochenek T; Wladysiuk M; Furtado C; Marković-Peković V; Mardare I; Meshkov D; Fürst J; Tomek D; Cortadellas MO; Zara C; Haycox A; Campbell S; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):251-261. PubMed ID: 30696372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3.
    Garrett Z; Imaz-Iglesia I; Willemsen A
    Int J Technol Assess Health Care; 2022 Jan; 38(1):e14. PubMed ID: 35086599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.
    Tsoi B; O'Reilly D; Masucci L; Drummond M; Goeree R
    J Popul Ther Clin Pharmacol; 2015; 22(1):e78-89. PubMed ID: 25715384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN HEALTHCARE SYSTEM IN SLOVENIA.
    Prevolnik Rupel V
    Int J Technol Assess Health Care; 2017 Jan; 33(3):360-364. PubMed ID: 28434423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.